Elsevier

Life Sciences

Volume 47, Issue 6, 1990, Pages 579-585
Life Sciences

Morphine-3-glucuronide - a potent antagonist of morphine analgesia

https://doi.org/10.1016/0024-3205(90)90619-3Get rights and content

Abstract

In this study, morphine-3-glucuronide (M3G), the major plasma and urinary metabolite of morphine, was shown to be a potent antagonist of morphine analgesia when administered to rats by the intra-cerebroventricular (i.c.v.) route. The antagonism of morphine analgesia was observed irrespective of whether i.c.v. M3G (2.5 or 3.0μg) was administered 15 mins prior to or 15 mins after i.c.v. morphine (20μg). When M3G (10mg) was administered intraperitoneally (i.p.) to rats 30–40 mins prior to morphine (1.5mg i.p.), the analgesic response was significantly reduced compared to administration of morphine (1.5mg i.p.) alone. It was further demonstrated that i.c.v. M3G (2.0μg) antagonized the analgesic effects of subsequently administered i.c.v. morphine-6-glucuronide (0.25μg).

References (11)

  • H. Yoshimura et al.

    Biochem. Pharmacol.

    (1973)
  • G.W. Pasternak et al.

    Life Sci.

    (1987)
  • C.J. Woolf

    Brain Research

    (1981)
  • F.S. Labella et al.

    Brain Research

    (1979)
  • K. Oguri et al.

    Life Sci

    (1987)
There are more references available in the full text version of this article.

Cited by (0)

View full text